Skip to main content

Table 2 Success rate and early hypertensive phase frequency in both groups

From: Comparison of 1-year outcomes after Ahmed glaucoma valve implantation with and without Ologen adjuvant

 

OAGV group

CAGV group

p-value

Complete success

4 (50.0%)

1 (8.3%)

0.035a

Qualified success

6 (75.0%)

6 (50.0%)

0.264a

Early hypertensive phase

1 (12.5%)

4 (33.3%)

0.375b

  1. aχ2-test; bFisher’s exact test; OAGV Ologen-augmented Ahmed glaucoma valve implantation, CAGV conventional Ahmed glaucoma valve implantation
Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us